Investors

Growing Shareholder Value

Press Releases

FDA Safety Study of Unloading the Left Ventricle for 30 Minutes Prior to Reperfusion in Heart Attack Patients is Safe and Feasible

Nov 11, 2018
Read More

Abiomed to Present at the Stephens 2018 Investment Conference in New York, NY

Nov 02, 2018
Read More

Abiomed Announces Q2 FY 2019 Record Revenue of $182 Million, up 37% Over Prior Year

Nov 01, 2018
Read More

Abiomed Second Quarter Fiscal 2019 Earnings and Conference Call Notification

Oct 11, 2018
Read More

Data Presented at TCT 2018 Shows Use of Impella and Best Practices Increases Cardiogenic Shock Survival

Sep 24, 2018
Read More

Abiomed to Showcase Expanded FDA Indications and Next Generation Heart Recovery Products at TCT 2018

Sep 19, 2018
Read More

Abiomed Announces Approval in India for the Impella 2.5®, Impella CP® and Impella 5.0® Heart Pumps and First Indian Patient Treated

Jul 26, 2018
Read More

Abiomed Announces Q1 FY 2019 Record Revenue of $180 Million, Up 36% Over Prior Year

Jul 26, 2018
Read More

Abiomed First Quarter Fiscal 2019 Earnings And Conference Call Notification

Jul 06, 2018
Read More

Abiomed to Present at the Jefferies 2018 Healthcare Conference

May 29, 2018
Read More
View all